Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Labeling DNA Probes03:31

Labeling DNA Probes

8.3K
DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
8.3K
Translesion DNA Polymerases02:10

Translesion DNA Polymerases

10.1K
Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
10.1K
Proofreading01:31

Proofreading

6.5K
Synthesis of new DNA molecules is carried out by the enzyme DNA polymerase, which adds nucleotides on the daughter strand complementary to the template DNA strand. DNA polymerase has a higher affinity to add the correct base and ensures fidelity during DNA replication. Furthermore,  it exhibits proofreading activity during replication, using an exonuclease domain that cuts off incorrect nucleotides from the nascent DNA strand.
Errors During Replication are Corrected by the DNA Polymerase...
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacy.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Long-term outcomes of ICE-guided left atrial appendage occlusion from a large single-center experience.

International journal of cardiology·2026
Same author

The uptake, intracellular trafficking and recycling of FcRn-blocking therapeutics in human endothelial cells in vitro.

Cellular immunology·2026
Same author

Caseous Mitral Annular Calcification Causing Left Ventricular Outflow Tract Obstruction and Embolic Stroke in Hypertrophic Cardiomyopathy.

JACC. Case reports·2026
Same author

<i>SHLD2</i> loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy.

Science advances·2026
Same author

The Role of Firmicutes in Coronary Artery Disease: A Taxonomic-Level Meta-Analysis of Mendelian Randomization Studies.

Current cardiology reviews·2026

Related Experiment Video

Updated: Aug 26, 2025

Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes
05:37

Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes

Published on: April 4, 2025

818

Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human

Martin L Stockley1, Amanda Ferdinand2, Giovanni Benedetti1

  • 1Artios Pharma Ltd., B940, Babraham Research Campus, CambridgeCB22 3FH, U. K.

Journal of Medicinal Chemistry
|October 6, 2022
PubMed
Summary

Researchers developed novel small molecule probes, ART558 and ART812, targeting human DNA polymerase theta (Polθ). These compounds show promise for treating cancers with DNA repair defects by stabilizing a closed enzyme conformation for inhibition.

More Related Videos

Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response
05:01

Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response

Published on: June 14, 2024

1.5K
DNA Polymerase Activity Assay Using Near-infrared Fluorescent Labeled DNA Visualized by Acrylamide Gel Electrophoresis
07:38

DNA Polymerase Activity Assay Using Near-infrared Fluorescent Labeled DNA Visualized by Acrylamide Gel Electrophoresis

Published on: October 6, 2017

14.2K

Related Experiment Videos

Last Updated: Aug 26, 2025

Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes
05:37

Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes

Published on: April 4, 2025

818
Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response
05:01

Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response

Published on: June 14, 2024

1.5K
DNA Polymerase Activity Assay Using Near-infrared Fluorescent Labeled DNA Visualized by Acrylamide Gel Electrophoresis
07:38

DNA Polymerase Activity Assay Using Near-infrared Fluorescent Labeled DNA Visualized by Acrylamide Gel Electrophoresis

Published on: October 6, 2017

14.2K

Area of Science:

  • Biochemistry
  • Structural Biology
  • Medicinal Chemistry

Background:

  • Human DNA polymerase theta (Polθ) is crucial for DNA double-strand break repair via microhomology.
  • Polθ is a potential therapeutic target for cancers with deficient DNA repair pathways, including BRCA-deficient cancers.

Purpose of the Study:

  • To describe the discovery and characterization of small molecule probes targeting Polθ.
  • To elucidate the mechanism of inhibition and guide rational drug optimization.

Main Methods:

  • Biochemical and biophysical characterization of Polθ inhibitors.
  • Co-crystallization of Polθ with small molecule ligands.
  • X-ray crystallography to determine enzyme-inhibitor structures.

Main Results:

  • Identification and characterization of ART558 (in vitro probe) and ART812 (in vivo probe).
  • Co-crystal structures reveal a unique inhibition mechanism involving stabilization of a closed enzyme conformation.
  • Structural data enables rational optimization focused on reducing ligand conformational flexibility.

Conclusions:

  • ART558 and ART812 are valuable chemical probes for studying Polθ function.
  • The identified mechanism of inhibition provides a foundation for developing novel Polθ-targeted cancer therapeutics.
  • Structural insights facilitate the design of optimized inhibitors with improved efficacy.